|
|
Article: Dr Reddy's sees full-year sales climb 11%.(Dr Reddy's Laboratories)(Brief Article)
- Article from:
- Pharma Marketletter
- Article date:
- June 7, 2004
CopyrightCOPYRIGHT 2004 Marketletter Publications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
India's Dr Reddy's Laboratories has posted revenues for the full year ending March 31 of 20 billion rupees ($442 million), marking solid 11% growth from the 18 billion rupees recorded for the prior year.
Regionally, sales from overseas markets increased 12% to reach 12.9 billion rupees, comprising 64% of total revenues. Combined US and European turnover also increased 12%, to 8.1 billion rupees, driven by the performance of ramipril in Europe and 14% growth of generics in the European market, the firm noted.
Revenues from the generics segment inched up 1.4% to 4.34 billion rupees, with sales from North America comprising 78% and Europe 21%. Sales in ...